Genus Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Genus Capital Management's AMGN Position: Q3 2026 in Review
Genus Capital Management reduced its Amgen (AMGN) stake by 77% in Q3 2026, selling an estimated $11.1M and leaving 8,277 shares worth $3.49M. The position accounts for 0.35% of the portfolio, ranked #85.
Genus Capital Management first reported a position in AMGN in Q2 2023 and has held it in 9 quarters since. The position peaked at $15.6M in Q1 2026. 3,276 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Genus Capital Management held 8,277 shares of Amgen worth $3.49M as of Q3 2026.
- Genus Capital Management sold 27,960 Amgen shares in Q3 2026, an estimated $11.1M.
- Amgen made up 0.35% of Genus Capital Management's portfolio in Q3 2026, its #85 holding.
- Genus Capital Management first reported a position in Amgen in Q2 2023 and has held it in 9 quarters since.
- Genus Capital Management's Amgen position peaked at $15.6M in Q1 2026.
- 3,276 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Genus Capital Management's 13F filing for Q3 2026, filed 4 Nov 2026.